
75.54 EUR (+12.1%)
13 analysts
What does it do?
Melexis is a Belgian semiconductor manufacturer specializing in sensors and integrated circuits for the automotive industry, with a business model based on the design and sale of high-value-added chips.
Listed on Euronext Bruselas · Symbol MELE.BR · EBR: MELE · Currency EUR
Key points
from its scores- ✓High-quality business7.1
- ✕Poor share-price trend2.6
- ✕Weak growth2.7
- ✕Unfavourable risk and backdrop4.0
AI analysis
bottom line, main risk, context and newsQuality and balance sheet are solid, but lack of growth and unsustainable payout limit near-term appeal.
Melexis presents solid financial health (Net Debt/EBITDA of 1.38, liquidity of 5.87) and excellent quality (ROE of 22.03%, ROIC of 20.79%), but its growth is weak (revenue +2.60%, earnings -19.20%) and its payout of 143.99% is unsustainable. Valuation is reasonable (forward P/E of 17.52), but momentum is negative.
The main risk is dependence on the automotive cycle, which is causing a decline in earnings (-19.20%) and could continue to pressure results if the sector does not recover.
Context and risks
No recent relevant news and no material exposure to current macro factors. Melexis is a Belgian semiconductor manufacturer with a healthy balance sheet (Net Debt/EBITDA of 1.38) and an operating margin of 17.77%. Its automotive sensor business is more tied to the automotive cycle than to interest rates or commodities.
Is Melexis stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 20% below the Technology median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 26.2 | 31.3 | −16% |
| EV / EBITDA | 15.6 | 20.4 | −24% |
| Price / book | 6.2 | 6.3 | −1% |
| Price / sales | 3.1 | 5.3 | −41% |
Sector: median of the 283 Technology companies analysed. In bold, the multiples used for the comparison.
Valuation score: 6.2 out of 10 (median for Technology: 5.3).
Average analyst target: 75.54 EUR, +12.1% versus the price.
A discount may reflect more risk or slower growth than its sector: Financial health 6.9 (sector 6.9), Growth 2.7 (sector 7.5).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Technology medianValuation
- P/E
- 26.2
- Forward P/E
- 17.5
- EV / EBITDA
- 15.6
- Price / book
- 6.2
- Price / sales
- 3.1
- PEG
- 1.73
- Market cap
- 2.7B EUR
- Enterprise value
- 3.0B EUR
Profitability
- ROE
- 22.0%
- ROA
- 10.0%
- ROIC (approx.)
- 20.8%
- Gross margin
- 39.4%
- Operating margin
- 17.8%
- Net margin
- 12.2%
- Free cash flow
- 107.2M EUR
- FCF yield
- 4.0%
- Cash conversion
- 56%
Solvency
- Total debt
- 301.0M EUR
- Net debt
- 263.7M EUR
- Cash
- 37.3M EUR
- EBITDA
- 191.4M EUR
- Net debt / EBITDA
- 1.38
- Debt / equity
- 69.09
- Current ratio
- 5.87
- Quick ratio
- 2.90
Growth
- Revenue growth
- +2.6%
- Earnings growth
- −19.2%
- EPS (TTM)
- 2.57 EUR
- EPS (forward)
- 3.85 EUR
Dividend
- Dividend yield
- 5.5%
- Payout
- 144.0%
Risk and market
- Beta
- 1.49
- Analyst consensus
- Hold (13)
- Target price
- 75.54 EUR
- 52-week range
- 48.60 – 86.70
Recent news
All MELE.BR news →Compare it with its sector
All 283 in Technology →Frequently asked questions about Melexis
Is Melexis stock cheap or expensive?
On P/E and EV / EBITDA, it trades 20% below the Technology median on average. Valuation score: 6.2 out of 10 (median for Technology: 5.3). Average analyst target: 75.54 EUR, +12.1% versus the price. This is not investment advice.
What score does Melexis get on MeridIAn Screener?
It scores 5.2 out of 10, rank 1,597 of 2,130 (better than 24% of the companies analysed). Its strongest category is Quality / Moat (7.1) and its weakest, Momentum (2.6). Analysis of 08/10/2026.
What is Melexis's P/E ratio?
Its P/E is 26.2: the share price equals 26.2 times earnings per share over the last 12 months. The Technology median is 31.3. Based on the earnings analysts expect, the forward P/E is 17.5.
How much is Melexis worth on the stock market?
Its market capitalisation is 2.7B EUR and its enterprise value, debt included, is 3.0B EUR.
How much debt does Melexis have?
Its net debt (debt minus cash) is 263.7M EUR. That is 1.38 times its EBITDA; the Technology median is 0.20.
Does Melexis pay a dividend?
Yes: its dividend yield is 5.49% and it pays out 144% of its earnings.
How has Melexis stock performed over the last year?
It has risen 10.1% over the last year, excluding dividends. Over the last 52 weeks it has traded between 48.60 and 86.70 EUR. Past performance does not guarantee future results.
What do analysts think of Melexis?
13 analysts cover it; their average recommendation is “Hold” and their average target is 75.54 EUR (+12.1% versus the price). It is an estimate, not market data.
